Nuclear oncology 2: Scintigrahic imaging

Razi Muzaffar, Osama Raslan, Medhat M. Osman

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Nuclear medicine has a major role in the management of malignant tumors. With the developments towards molecular imaging and the technological advancement of scanners providing a fusion of both physiologic and anatomic imaging, it has even become a more integral part of management protocols. This role includes detection of malignant tumors, staging and restaging of the disease, early detection of recurrence, evaluation of the response to therapy, and prediction of the prognosis. Radionuclide diagnosis and therapy for tumors depend on the characteristics of tumors including increased vascularization, increased blood fl ow, newly proliferated capillaries with more permeable walls, increased metabolic activity of cells, increased energy demand, high density of some common antigens or several specifi c antigens, and several specifi c receptors as discussed in the previous chapter.

Original languageEnglish (US)
Title of host publicationThe Pathophysiologic Basis of Nuclear Medicine
PublisherSpringer International Publishing
Pages369-399
Number of pages31
ISBN (Electronic)9783319061122
ISBN (Print)9783319061115
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Oncology
Tumors
Imaging techniques
Antigens
Neoplasms
Molecular Imaging
Neoplasm Staging
Nuclear Medicine
Molecular imaging
Nuclear medicine
Radioisotopes
Early Diagnosis
Recurrence
Blood
Fusion reactions
Cells
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Muzaffar, R., Raslan, O., & Osman, M. M. (2015). Nuclear oncology 2: Scintigrahic imaging. In The Pathophysiologic Basis of Nuclear Medicine (pp. 369-399). Springer International Publishing. https://doi.org/10.1007/978-3-319-06112-2_12

Nuclear oncology 2 : Scintigrahic imaging. / Muzaffar, Razi; Raslan, Osama; Osman, Medhat M.

The Pathophysiologic Basis of Nuclear Medicine. Springer International Publishing, 2015. p. 369-399.

Research output: Chapter in Book/Report/Conference proceedingChapter

Muzaffar, R, Raslan, O & Osman, MM 2015, Nuclear oncology 2: Scintigrahic imaging. in The Pathophysiologic Basis of Nuclear Medicine. Springer International Publishing, pp. 369-399. https://doi.org/10.1007/978-3-319-06112-2_12
Muzaffar R, Raslan O, Osman MM. Nuclear oncology 2: Scintigrahic imaging. In The Pathophysiologic Basis of Nuclear Medicine. Springer International Publishing. 2015. p. 369-399 https://doi.org/10.1007/978-3-319-06112-2_12
Muzaffar, Razi ; Raslan, Osama ; Osman, Medhat M. / Nuclear oncology 2 : Scintigrahic imaging. The Pathophysiologic Basis of Nuclear Medicine. Springer International Publishing, 2015. pp. 369-399
@inbook{b125ef45cb1140dc839e17750206c195,
title = "Nuclear oncology 2: Scintigrahic imaging",
abstract = "Nuclear medicine has a major role in the management of malignant tumors. With the developments towards molecular imaging and the technological advancement of scanners providing a fusion of both physiologic and anatomic imaging, it has even become a more integral part of management protocols. This role includes detection of malignant tumors, staging and restaging of the disease, early detection of recurrence, evaluation of the response to therapy, and prediction of the prognosis. Radionuclide diagnosis and therapy for tumors depend on the characteristics of tumors including increased vascularization, increased blood fl ow, newly proliferated capillaries with more permeable walls, increased metabolic activity of cells, increased energy demand, high density of some common antigens or several specifi c antigens, and several specifi c receptors as discussed in the previous chapter.",
author = "Razi Muzaffar and Osama Raslan and Osman, {Medhat M.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-3-319-06112-2_12",
language = "English (US)",
isbn = "9783319061115",
pages = "369--399",
booktitle = "The Pathophysiologic Basis of Nuclear Medicine",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Nuclear oncology 2

T2 - Scintigrahic imaging

AU - Muzaffar, Razi

AU - Raslan, Osama

AU - Osman, Medhat M.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Nuclear medicine has a major role in the management of malignant tumors. With the developments towards molecular imaging and the technological advancement of scanners providing a fusion of both physiologic and anatomic imaging, it has even become a more integral part of management protocols. This role includes detection of malignant tumors, staging and restaging of the disease, early detection of recurrence, evaluation of the response to therapy, and prediction of the prognosis. Radionuclide diagnosis and therapy for tumors depend on the characteristics of tumors including increased vascularization, increased blood fl ow, newly proliferated capillaries with more permeable walls, increased metabolic activity of cells, increased energy demand, high density of some common antigens or several specifi c antigens, and several specifi c receptors as discussed in the previous chapter.

AB - Nuclear medicine has a major role in the management of malignant tumors. With the developments towards molecular imaging and the technological advancement of scanners providing a fusion of both physiologic and anatomic imaging, it has even become a more integral part of management protocols. This role includes detection of malignant tumors, staging and restaging of the disease, early detection of recurrence, evaluation of the response to therapy, and prediction of the prognosis. Radionuclide diagnosis and therapy for tumors depend on the characteristics of tumors including increased vascularization, increased blood fl ow, newly proliferated capillaries with more permeable walls, increased metabolic activity of cells, increased energy demand, high density of some common antigens or several specifi c antigens, and several specifi c receptors as discussed in the previous chapter.

UR - http://www.scopus.com/inward/record.url?scp=84944611257&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944611257&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-06112-2_12

DO - 10.1007/978-3-319-06112-2_12

M3 - Chapter

AN - SCOPUS:84944611257

SN - 9783319061115

SP - 369

EP - 399

BT - The Pathophysiologic Basis of Nuclear Medicine

PB - Springer International Publishing

ER -